国际妇产科学杂志 ›› 2021, Vol. 48 ›› Issue (2): 203-208.doi: 10.12280/gjfckx.20200795
收稿日期:
2020-08-26
出版日期:
2021-04-15
发布日期:
2021-04-16
通讯作者:
王勇
E-mail:yongwang@nju.edu.cn
基金资助:
XU Qian, LIU Bin, WANG Dao-juan, WANG Yong△()
Received:
2020-08-26
Published:
2021-04-15
Online:
2021-04-16
Contact:
WANG Yong
E-mail:yongwang@nju.edu.cn
摘要:
多囊卵巢综合征是一种育龄女性常见的内分泌紊乱疾病,以雄激素过多和胰岛素抵抗为主要特征,病理生理突出表现为卵泡发育不良。其发病原因至今尚不明确,现多认为雄激素在其发病中起重要作用。在胚胎早期发育过程中,过量雄激素暴露影响卵巢外神经内分泌系统,类固醇激素负反馈途径缺陷与促性腺激素释放激素神经元活性异常引起下丘脑-垂体-性腺轴损害,最终导致下游靶器官的形态功能异常而产生相应临床改变。这一过程中的主要微观机制主要涉及弓状核中的kisspeptin-神经激肽B-强啡肽神经元以及GABA能神经元的电生理和分泌活动的改变等。综述胚胎发育早期雄激素过量引起的神经内分泌改变及其导致多囊卵巢综合征的主要证据与可能机制,并对胚胎发育期高雄激素诱导神经内分泌紊乱的临床应用作出展望。
许倩, 刘斌, 王道娟, 王勇. 胚胎发育期高雄激素诱导多囊卵巢综合征患者内分泌紊乱的中枢机制[J]. 国际妇产科学杂志, 2021, 48(2): 203-208.
XU Qian, LIU Bin, WANG Dao-juan, WANG Yong. The Central Mechanism of Endocrine Disorder Induced by Androgen in PCOS Patients[J]. Journal of International Obstetrics and Gynecology, 2021, 48(2): 203-208.
[1] |
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod, 2004,19(1):41-47. doi: 10.1093/humrep/deh098.
doi: 10.1093/humrep/deh098 pmid: 14688154 |
[2] |
Escobar-Morreale HF. Polycystic ovary syndrome: definition,aetiology,diagnosis and treatment[J]. Nat Rev Endocrinol, 2018,14(5):270-284. doi: 10.1038/nrendo.2018.24.
pmid: 29569621 |
[3] |
Caldwell A, Edwards MC, Desai R, et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome[J]. Proc Natl Acad Sci U S A, 2017,114(16):E3334-E3343. doi: 10.1073/pnas.1616467114.
doi: 10.1073/pnas.1616467114 pmid: 28320971 |
[4] |
Walters KA, Bertoldo MJ, Handelsman DJ. Evidence from animal models on the pathogenesis of PCOS[J]. Best Pract Res Clin Endocrinol Metab, 2018,32(3):271-281. doi: 10.1016/j.beem.2018.03.008.
doi: 10.1016/j.beem.2018.03.008 pmid: 29779581 |
[5] |
Pignatelli D. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome[J]. Front Horm Res, 2013,40:158-170. doi: 10.1159/000342179.
doi: 10.1159/000342179 pmid: 24002412 |
[6] |
Escobar-Morreale HF, San Millán JL. Abdominal adiposity and the polycystic ovary syndrome[J]. Trends Endocrinol Metab, 2007,18(7):266-272. doi: 10.1016/j.tem.2007.07.003.
doi: 10.1016/j.tem.2007.07.003 pmid: 17693095 |
[7] |
Hakim C, Padmanabhan V, Vyas AK. Gestational Hyperandrogenism in Developmental Programming[J]. Endocrinology, 2017,158(2):199-212. doi: 10.1210/en.2016-1801.
doi: 10.1210/en.2016-1801 pmid: 27967205 |
[8] |
Moore AM, Prescott M, Campbell RE. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome[J]. Endocrinology, 2013,154(2):796-806. doi: 10.1210/en.2012-1954.
doi: 10.1210/en.2012-1954 |
[9] |
Walters KA. Androgens in polycystic ovary syndrome: lessons from experimental models[J]. Curr Opin Endocrinol Diabetes Obes, 2016,23(3):257-263. doi: 10.1097/MED.0000000000000245.
doi: 10.1097/MED.0000000000000245 pmid: 26866639 |
[10] |
Caldwell AS, Eid S, Kay CR, et al. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization[J]. Endocrinology, 2015,156(4):1441-1452. doi: 10.1210/en.2014-1887.
pmid: 25643156 |
[11] |
Silva MS, Prescott M, Campbell RE. Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS[J]. JCI Insight, 2018,3(7):e99405. doi: 10.1172/jci.insight.99405.
doi: 10.1172/jci.insight.99405 |
[12] |
Kawwass JF, Sanders KM, Loucks TL, et al. Increased cerebrospinal fluid levels of GABA,testosterone and estradiol in women with polycystic ovary syndrome[J]. Hum Reprod, 2017,32(7):1450-1456. doi: 10.1093/humrep/dex086.
doi: 10.1093/humrep/dex086 pmid: 28453773 |
[13] |
Cheng XB, Jimenez M, Desai R, et al. Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice[J]. Am J Physiol Endocrinol Metab, 2013,305(6):E717-E726. doi: 10.1152/ajpendo.00263.2013.
doi: 10.1152/ajpendo.00263.2013 pmid: 23880317 |
[14] |
Moore AM, Campbell RE. Polycystic ovary syndrome: Understanding the role of the brain[J]. Front Neuroendocrinol, 2017,46:1-14. doi: 10.1016/j.yfrne.2017.05.002.
doi: 10.1016/j.yfrne.2017.05.002 pmid: 28551304 |
[15] | Herbison AE. Physiology of the gonadotropin-releasing hormone neuronal network[M]//Neill JD. Knobil and Neill′s Physiology of Reproduction. Academic Press, 2006: 1415-1482. |
[16] |
Moore AM, Campbell RE. The neuroendocrine genesis of polycystic ovary syndrome: A role for arcuate nucleus GABA neurons[J]. J Steroid Biochem Mol Biol, 2016,160:106-117. doi: 10.1016/j.jsbmb.2015.10.002.
pmid: 26455490 |
[17] |
Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental,clinical,and genetic association studies[J]. J Clin Endocrinol Metab, 2006,91(5):1660-1666. doi: 10.1210/jc.2005-2757.
doi: 10.1210/jc.2005-2757 pmid: 16522691 |
[18] |
Foecking EM, Szabo M, Schwartz NB, et al. Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges,suppression of progesterone receptor gene expression,and acceleration of the gonadotropin-releasing hormone pulse generator[J]. Biol Reprod, 2005,72(6):1475-1483. doi: 10.1095/biolreprod.105.039800.
pmid: 15744016 |
[19] |
Maliqueo M, Galgani JE, Pérez-Bravo F, et al. Relationship of serum adipocyte-derived proteins with insulin sensitivity and reproductive features in pre-pubertal and pubertal daughters of polycystic ovary syndrome women[J]. Eur J Obstet Gynecol Reprod Biol, 2012,161(1):56-61. doi: 10.1016/j.ejogrb.2011.12.012.
doi: 10.1016/j.ejogrb.2011.12.012 pmid: 22277163 |
[20] |
Zuloaga DG, Heck AL, De Guzman RM, et al. Roles for androgens in mediating the sex differences of neuroendocrine and behavioral stress responses[J]. Biol Sex Differ, 2020,11(1):44. doi: 10.1186/s13293-020-00319-2.
doi: 10.1186/s13293-020-00319-2 pmid: 32727567 |
[21] |
Wang F, Pan J, Liu Y, et al. Alternative splicing of the androgen receptor in polycystic ovary syndrome[J]. Proc Natl Acad Sci U S A, 2015,112(15):4743-4748. doi: 10.1073/pnas.1418216112.
pmid: 25825716 |
[22] |
Penatti CA, Davis MC, Porter DM, et al. Altered GABAA receptor-mediated synaptic transmission disrupts the firing of gonadotropin-releasing hormone neurons in male mice under conditions that mimic steroid abuse[J]. J Neurosci, 2010,30(19):6497-6506. doi: 10.1523/JNEUROSCI.5383-09.2010.
pmid: 20463213 |
[23] |
Ruka KA, Burger LL, Moenter SM. Both Estrogen and Androgen Modify the Response to Activation of Neurokinin-3 and κ-Opioid Receptors in Arcuate Kisspeptin Neurons From Male Mice[J]. Endocrinology, 2016,157(2):752-763. doi: 10.1210/en.2015-1688.
doi: 10.1210/en.2015-1688 pmid: 26562263 |
[24] |
Walters KA, Edwards MC, Tesic D, et al. The Role of Central Androgen Receptor Actions in Regulating the Hypothalamic-Pituitary-Ovarian Axis[J]. Neuroendocrinology, 2018,106(4):389-400. doi: 10.1159/000487762.
doi: 10.1159/000487762 pmid: 29635226 |
[25] |
Amodei R, Gribbin K, He W, et al. Role for Kisspeptin and Neurokinin B in Regulation of Luteinizing Hormone and Testosterone Secretion in the Fetal Sheep[J]. Endocrinology, 2020,161(4):bqaa013. doi: 10.1210/endocr/bqaa013.
doi: 10.1210/endocr/bqaa022 pmid: 32052048 |
[26] |
George JT, Kakkar R, Marshall J, et al. Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized,Placebo-Controlled Trial[J]. J Clin Endocrinol Metab, 2016,101(11):4313-4321. doi: 10.1210/jc.2016-1202.
pmid: 27459523 |
[27] |
Abbott DH. Neuronal androgen receptor: Molecular gateway to polycystic ovary syndrome?[J]. Proc Natl Acad Sci U S A, 2017,114(16):4045-4047. doi: 10.1073/pnas.1703436114.
doi: 10.1073/pnas.1703436114 pmid: 28377515 |
[28] |
Kumar D, Candlish M, Periasamy V, et al. Specialized subpopulations of kisspeptin neurons communicate with GnRH neurons in female mice[J]. Endocrinology, 2015,156(1):32-38. doi: 10.1210/en.2014-1671.
doi: 10.1210/en.2014-1671 pmid: 25337655 |
[29] |
Skorupskaite K, George JT, Anderson RA. The kisspeptin-GnRH pathway in human reproductive health and disease[J]. Hum Reprod Update, 2014,20(4):485-500. doi: 10.1093/humupd/dmu009.
doi: 10.1093/humupd/dmu009 pmid: 24615662 |
[30] |
Clarkson J, Han SY, Piet R, et al. Definition of the hypothalamic GnRH pulse generator in mice[J]. Proc Natl Acad Sci U S A, 2017,114(47):E10216-E10223. doi: 10.1073/pnas.1713897114.
pmid: 29109258 |
[31] |
Sullivan SD, Moenter SM. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder[J]. Proc Natl Acad Sci U S A, 2004,101(18):7129-7134. doi: 10.1073/pnas.0308058101.
pmid: 15096602 |
[32] |
Kawwass JF, Sanders KM, Loucks TL, et al. Increased cerebrospinal fluid levels of GABA,testosterone and estradiol in women with polycystic ovary syndrome[J]. Hum Reprod, 2017,32(7):1450-1456. doi: 10.1093/humrep/dex086.
doi: 10.1093/humrep/dex086 pmid: 28453773 |
[33] |
Zhang L, Li H, Li S, et al. Reproductive and metabolic abnormalities in women taking valproate for bipolar disorder: a meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2016,202:26-31. doi: 10.1016/j.ejogrb.2016.04.038.
pmid: 27160812 |
[34] |
Berg T, Silveira MA, Moenter SM. Prepubertal Development of GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons and Postsynaptic Response Are Altered by Prenatal Androgenization[J]. J Neurosci, 2018,38(9):2283-2293. doi: 10.1523/JNEUROSCI.2304-17.2018.
doi: 10.1523/JNEUROSCI.2304-17.2018 pmid: 29374136 |
[35] |
Walters KA, Gilchrist RB, Ledger WL, et al. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins[J]. Trends Endocrinol Metab, 2018,29(12):841-852. doi: 10.1016/j.tem.2018.08.005.
doi: 10.1016/j.tem.2018.08.005 pmid: 30195991 |
[1] | 徐淑颖, 徐海鹏, 王丽娜, 张阳. 锌与多囊卵巢综合征的关系[J]. 国际妇产科学杂志, 2025, 52(2): 217-221. |
[2] | 闫辉波, 张琳. 1990—2021年中国及全球多囊卵巢综合征疾病负担及预测分析[J]. 国际妇产科学杂志, 2025, 52(2): 228-233. |
[3] | 张栋, 王筝, 李凯, 卞文丽, 高志华. 非妊娠期重度自发性卵巢过度刺激综合征一例[J]. 国际妇产科学杂志, 2025, 52(1): 79-83. |
[4] | 胡蝶, 任佳杰, 刘佳宁, 冯晓玲. MAPK信号通路在PCOS中的作用机制及中药单体的药理研究进展[J]. 国际妇产科学杂志, 2024, 51(6): 684-691. |
[5] | 李东楠, 向蓉, 汪海洋, 孙淼. 卵巢颗粒细胞凋亡在多囊卵巢综合征中的调控机制及中医药干预研究进展[J]. 国际妇产科学杂志, 2024, 51(6): 692-697. |
[6] | 李晨曦, 范梦笑, 吴林玲, 窦真, 贾佳, 孙娅瑄. 高雄激素诱导多囊卵巢综合征神经内分泌紊乱的研究进展[J]. 国际妇产科学杂志, 2024, 51(6): 698-702. |
[7] | 尹雨鑫, 王长河. 完全型雄激素不敏感综合征合并无性细胞瘤一例[J]. 国际妇产科学杂志, 2024, 51(4): 392-394. |
[8] | 郭希, 魏佳, 杨永秀. 导致子宫内膜疾病的激素通路及调节因素[J]. 国际妇产科学杂志, 2024, 51(4): 395-400. |
[9] | 张蓝月, 申复进. 过继性细胞免疫治疗在宫颈癌中的研究进展[J]. 国际妇产科学杂志, 2024, 51(3): 253-257. |
[10] | 孙艺文, 熊可, 张梓絮, 翁雅婧, 王勇. 双酚A对多囊卵巢综合征发病机制的影响[J]. 国际妇产科学杂志, 2023, 50(6): 601-605. |
[11] | 李振英, 孙晓彤, 邢广阳, 李晶晶, 柳婷婷, 张一凡. 鞘脂代谢与妇科良恶性疾病的研究进展[J]. 国际妇产科学杂志, 2023, 50(6): 649-654. |
[12] | 黄晓彤, 程湘玮, 张阳. 子痫前期母胎界面TLR4作用的研究进展[J]. 国际妇产科学杂志, 2023, 50(6): 689-694. |
[13] | 胡悦, 盛红娜, 梁美育, 范卓然, 华绍芳. 雌激素受体信号通路与子痫前期的关系[J]. 国际妇产科学杂志, 2023, 50(6): 695-698. |
[14] | 徐惠, 解秀珍. 多囊卵巢综合征患者负性情绪的研究进展[J]. 国际妇产科学杂志, 2023, 50(5): 530-534. |
[15] | 寇丽辉, 宋殿荣, 郭洁. 负性情绪对多囊卵巢综合征不孕症的影响[J]. 国际妇产科学杂志, 2023, 50(5): 535-539. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||